Fact check
“HHS recommended placing cannabis in Schedule III after reconsidering its potential for abuse.”
Reasoning
The provided sources explicitly mention that HHS recommended reclassifying cannabis to Schedule III due to its potential for abuse. No contradictory evidence is presented.
On confidence: Multiple secondary reports directly state that HHS recommended placing cannabis in Schedule III based on its potential for abuse.
Important context
The recommendation pertains to the federal scheduling of cannabis and reflects HHS's assessment of abuse potential, not a final scheduling decision.
Evidence
Supporting (2)
- Tier 3 — Secondary reporting35 Years Ago, a Judge Said Marijuana Did Not Belong in Schedule I. HHS Finally Agrees.
Schedule I to Schedule V, the least restrictive category, or deschedule it entirely. The BNDD initially refused even to consider the petition, claiming that it would violate the Single Convention on Narcotic Drugs. Even if that might be…
- Tier 3 — Secondary reportingFederal drug scheduling relies on vague criteria, GAO report finds
"potential for abuse," recommended placing it in Schedule III, which includes prescription drugs such as ketamine, anabolic steroids, and Tylenol with codeine. Last April, Acting Attorney General Todd Blanche issued a final rule that…
Limitations
The evidence consists of secondary reporting articles; primary HHS documents were not directly accessed. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 1, 2026, 4:49 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Hazy Drug Classification Criteria Invite Dubious Bureaucratic JudgmentsReason · Jacob Sullum